Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier

Journal of Neurochemistry

Volumn 96, Issue 4, 2006, Pages 1051-1059

  Deguchi, Tsuneo ^a   Isozaki, Kouya ^a   Yousuke, Kouno ^a   Terasaki, Tetsuya ^b,c   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Blood brain barrier; Efflux transport; Organic anion transporter; Uremic encephalopathy; Uremic toxin

Indexed keywords

CARBON 14; COMPLEMENTARY DNA; COMPLEMENTARY RNA; DIGOXIN; HIPPURIC ACID; INDOLEACETIC ACID; INULIN; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; PENICILLIN G; PROPIONIC ACID DERIVATIVE; TAUROCHOLIC ACID; TRITIUM; UNCLASSIFIED DRUG; UROFURAN ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANION TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CONTROLLED STUDY; DRUG TRANSPORT; GENE EXPRESSION; ISOTOPE LABELING; KINETICS; MALE; NEUROTOXICITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; UREMIA; XENOPUS LAEVIS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; FEMALE; FURANS; HIPPURATES; INDOLEACETIC ACIDS; KINETICS; MALE; OOCYTES; ORGANIC ANION TRANSPORTERS; PROPIONIC ACIDS; RATS; RATS, WISTAR; UREMIA; XENOPUS LAEVIS;

ANIMALIA; XENOPUS LAEVIS;

EID: 33645110122     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03550.x     Document Type: Article

References (33)

1. Asaba H. Hosoya K. Takanaga H. Ohtsuki S. Tamura E. Takizawa T. Terasaki T. 2000 Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2 JNeurochem 75 1907 1916
2. Brouns R. De Deyn PP. 2004 Neurological complications in renal failure: a review ClinNeurolNeurosurg 107 1 16
3. Costigan MG. Callaghan CA. Lindup WE. 1996 Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure? Nephron 73 169 173
4. 2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins Kidney Int 63 1764 1775
5. Deguchi T. Ohtsuki S. Otagiri M. Takanaga H. Asaba H. Mori S. Terasaki T. 2002 Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney Kidney Int 61 1760 1768
6. Deguchi T. Kusuhara H. Takadate A. Endou H. Otagiri M. Sugiyama Y. 2004 Characterization of uremic toxin transport by organic anion transporters in the kidney Kidney Int 65 162 174
7. Gao B. Stieger B. Noe B. Fritschy JM. Meier PJ. 1999 Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain JHistochemCytochem 47 1255 1264
8. Hosoya K. Asaba H. Terasaki T. 2000 Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats Life Sci 67 2699 2711
9. Kakee A. Terasaki T. Sugiyama Y. 1996 Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier JPharmacolExpTher 277 1550 1559
10. Kikuchi R. Kusuhara H. Sugiyama D. Sugiyama Y. 2003 Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier JPharmacolExpTher 306 51 58
11. Kikuchi R. Kusuhara H. Abe T. Endou H. Sugiyama Y. 2004 Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier JPharmacolExpTher 311 1147 1153
12. Kitazawa T. Terasaki T. Suzuki H. Kakee A. Sugiyama Y. 1998 Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides JPharmacolExpTher 286 890 895
13. Kusuhara H. Sugiyama Y. 2001a Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1) Drug DiscovToday 6 150 156
14. Kusuhara H. Sugiyama Y. 2001b Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2) Drug DiscovToday 6 206 212
15. Loscher W. Potschka H. 2005 Blood-brain barrier active efflux transporters: ATP-binding cassette gene family Neurorxq7 2 86 98
16. Moe SM. Sprague SM. 1994 Uremic encephalopathy ClinNephrol 42 251 256
17. Mori S. Takanaga H. Ohtsuki S. Deguchi T. Kang YS. Hosoya K. Terasaki T. 2003 Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells JCerebBlood Flow Metab 23 432 440
18. Mori S. Ohtsuki S. Takanaga H. Kikkawa T. Kang YS. Terasaki T. 2004 Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs JNeurochem 90 931 941
19. Muting D. 1965 Studies on the pathogenesis of uremia. Comparative determinations of glucuronic acid, indican, free and bound phenols in the serum, cerebrospinal fluid, and urine of renal diseases with and without uremia ClinChimActa 12 551 554
20. Niwa T. 1996 Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure SeminNephrol 16 167 182
21. Ohtsuki S. Asaba H. Takanaga H. Deguchi T. Hosoya K. Otagiri M. Terasaki T. 2002 Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain JNeurochem 83 57 66
22. Pardridge WM. 1999 Blood-brain barrier biology and methodology JNeurovirol 5 556 569
23. Paxinos G. Watson C. 1986 The Rat Brain in Stereotaxic Coordinates Academic Press New York
24. Porter RD. Cathcart-Rake WF. Wan SH. Whittier FC. Grantham JJ. 1975 Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man JLabClinMed 85 723 731
25. Saito H. Masuda S. Inui K. 1996 Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney JBiolChem 271 20719 20725
26. Sakai T. Maruyama T. Imamura H. Shimada H. Otagiri M. 1996 Mechanism of stereoselective serum binding of ketoprofen after hemodialysis JPharmacolExpTher 278 786 792
27. Schoots AC. De Vries PM. Thiemann R. Hazejager WA. Visser SL. Oe PL. 1989 Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failure ClinChimActa 185 91 107
28. Smogorzewski MJ. 2001 Central nervous dysfunction in uremia AmJKidney Dis 38 S122 S128
29. Sugiyama D. Kusuhara H. Shitara Y. Abe T. Meier PJ. Sekine T. Endou H. Suzuki H. Sugiyama Y. 2001 Characterization of the efflux transport of 17beta-estradiol- d -17beta-glucuronide from the brain across the blood-brain barrier JPharmacolExpTher 298 316 322
30. Tsutsumi Y. Maruyama T. Takadate A. Goto M. Matsunaga H. Otagiri M. 1999 Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin PharmRes 16 916 923
31. Tsutsumi Y. Deguchi T. Takano M. Takadate A. Lindup WE. Otagiri M. 2002 Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat JPharmacolExpTher 303 880 887
32. Vanholder R. De Smet R. Glorieux G. et al. 2003 Review on uremic toxins: classification, concentration, and interindividual variability Kidney Int 63 1934 1943
33. Yamaoka K. Tanigawara Y. Nakagawa T. Uno T. 1981 A pharmacokinetic analysis program (multi) for microcomputer JPharmacobiodyn 4 879 885